AP & Telangana State Head – Anandam Dundi :-
On Friday, shares of Murae Organisor Limited (Formerly known as Earum Pharmaceuticals Limited) hit a 5 per cent upper circuit to Re 0.64 per share from its previous closing of Re 0.61 per share. The stock’s 52-week high is Rs 1.24 per share and its 52-week low is Re 0.47 per share.
Murae Organisor Ltd., an Ahmedabad-based company, formerly known as Earum Pharmaceuticals Limited, has announced that its 13th Annual General Meeting (AGM) will be held on Tuesday, September 30, 2025, at 01:00 P.M. The company’s Annual Report for the financial year 2024-25, submitted to the BSE Limited, outlines a period of significant strategic shifts and financial performance, alongside critical observations from both its Statutory and Secretarial Auditors. Key Agenda for the 13th AGM: Shareholders at the upcoming AGM will consider and adopt the Audited Financial Statement for the year ended March 31, 2025, along with the Board’s and Auditor’s reports.
About the Company
Murae Organisor Ltd, incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.
According to Quarterly Results, the net sales increased by 1,635 per cent to Rs 3.99 crore and net profit increased by 3,200 per cent to Rs 7.44 crore in Q1FY26 compared to Q1FY25. In its annual results, the net sales increased by 33,554 per cent to Rs 854.82 crore and net profit increased by 14,940 per cent to Rs 7.52 crore in FY25 compared to FY24
The company has a market cap of Rs 137 crore and its 100 per cent stake is owned by public shareholders. The stock is up over 33 per cent from its 52-week low of Rs 0.47 per share.